Aspirin fails pregnancy test

THE LARGEST study of the effects of low dose aspirin on pregnant women shows it has failed to make its expected impact on a common and dangerous complication of pregnancy, writes Celia Hall.

Pre-eclampsia can threaten the life of the mother and her baby, causing very high blood pressure, swelling and kidney damage. It affects more than 50,000 pregnant women a year in Britain. Small studies had suggested that very low dose aspirin might reduce cases by half.

But a study of 9,364 women in 16 countries, reported in tomorrow's Lancet, shows low dose aspirin only reduces the risk of pre-eclampsia by about 25 per cent, with no clear benefit to the baby. The researchers conclude aspirin might still be useful for women who get the symptoms early in pregnancy.

Comments